Product Information
VIMPAT 150 MG TABLET is a brand product labeled by UCB, Inc., priced at $19.6209 per EA under NDC 00131247960. Its NADAC has been published 657 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the lacosamide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
150 mg/1
Manufacturer
UCB, Inc.NDC
00131247960
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LACOSAMIDEApproval Type
New Drug (NDA)
FDA Application
NDA022253On Market Since
5/26/2009
Pharmacological Classes
Price Statistics
The NADAC for VIMPAT 150 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 114.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $19.6209 per EA |
|---|---|
| All-time high | $19.6382 (Jun 10, 2026) |
| All-time low | $9.1281 (Nov 28, 2013) |
| 52-week high | $19.6382 |
| 52-week low | $19.1405 |
| Median price | $15.0584 |
| Average price | $14.9020 |
| Largest weekly change | +9.9% (Jan 11, 2017) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VIMPAT 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VIMPAT 150 MG TABLET, manufactured by UCB, Inc., is $19.6209 per EA (NDC 00131247960), effective Jun 24, 2026.
How has the price of VIMPAT 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for VIMPAT 150 MG TABLET has risen 114.9%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VIMPAT 150 MG TABLET?
Since Nov 28, 2013, the NADAC for VIMPAT 150 MG TABLET has ranged from a low of $9.1281 (Nov 28, 2013) to a high of $19.6382 (Jun 10, 2026), with a median of $15.0584 per EA.
Are there cheaper alternatives to VIMPAT 150 MG TABLET?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LACOSAMIDE 150 MG TABLET, is $0.2075 per EA — about 99% below VIMPAT 150 MG TABLET.
Who manufactures VIMPAT 150 MG TABLET?
VIMPAT 150 MG TABLET (NDC 00131247960) is labeled by UCB, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification